Page 281 - Read Online
P. 281

84.  Richardson WD, Kessaris N, Pringle N. Oligodendrocyte wars. Nat   protects oligodendrocytes and restricts demyelination in a mouse
              Rev Neurosci 2006;7:11‑8.                           model of viral‑induced demyelination. PLoS One 2010;5:e11340.
           85.  Liu J, Casaccia P. Epigenetic regulation of oligodendrocyte identity.   100. Kerstetter AE, Padovani‑Claudio DA, Bai L, Miller RH. Inhibition of
              Trends Neurosci 2010;33:193‑201.                    CXCR2 signaling promotes recovery in models of multiple sclerosis.
           86.  Amor  S, Puentes F, Baker D, van der Valk P. Inflammation in   Exp Neurol 2009;220:44‑56.
              neurodegenerative diseases. Immunology 2010;129:154‑69.  101. Albrecht  PJ, Murtie  JC, Ness  JK, Redwine  JM, Enterline  JR,
           87.  Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C.   Armstrong RC, Levison SW. Astrocytes produce CNTF during the
              The role of macrophage/microglia and astrocytes in the pathogenesis   remyelination phase of viral‑induced spinal cord demyelination to
              of three neurologic disorders: HIV‑associated dementia, Alzheimer   stimulate FGF‑2 production. Neurobiol Dis 2003;13:89‑101.
              disease, and multiple sclerosis. J Neurol Sci 2002;202:13‑23.  102. Dutta R, McDonough J, Chang A, Swamy L, Siu A, Kidd GJ,
           88.  Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation:   Rudick R, Mirnics K, Trapp BD. Activation of the ciliary neurotrophic
              a pathological perspective. J Neuroinflammation 2004;1:14.  factor (CNTF) signalling pathway in cortical neurons of multiple
           89.  Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N. Can   sclerosis patients. Brain 2007;130:2566‑76.
              we switch microglia’s phenotype to foster neuroprotection? Focus   103. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R,
              on multiple sclerosis. Immunology 2014;141:328‑39.  Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. CNTF is a
           90.  Kotter MR, Zhao C, van Rooijen N, Franklin RJ. Macrophage‑depletion   major protective factor in demyelinating CNS disease: a neurotrophic
              induced impairment of experimental CNS remyelination is associated   cytokine as modulator in neuroinflammation. Nat Med 2002;8:620‑4.
              with a reduced oligodendrocyte progenitor cell response and altered   104. Vernerey J, Macchi M, Magalon K, Cayre M, Durbec P. Ciliary
              growth factor expression. Neurobiol Dis 2005;18:166‑75.  neurotrophic factor controls progenitor migration during
           91.  Olah  M, Amor  S, Brouwer  N, Vinet  J, Eggen  B, Biber  K,   remyelination in the adult rodent brain. J Neurosci 2013;33:3240‑50.
              Boddeke HW. Identification of a microglia phenotype supportive   105. Sairanen  TR, Lindsberg  PJ, Brenner  M, Siren  AL. Global
              of remyelination. Glia 2012;60:306‑21.              forebrain ischemia results in differential cellular expression of
           92.  Perez Estrada C, Covacu R, Sankavaram SR, Svensson M, Brundin L.   interleukin‑1beta (IL‑1beta) and its receptor at mRNA and protein
              Oxidative stress increases neurogenesis and oligodendrogenesis in   level. J Cereb Blood Flow Metab 1997;17:1107‑20.
              adult neural progenitor cells. Stem Cells Dev 2014;23:2311‑27.  106. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin‑1beta
           93.  Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ.   promotes repair of the CNS. J Neurosci 2001;21:7046‑52.
              How factors secreted from astrocytes impact myelin repair.   107. Merrill JE. Effects of interleukin‑1 and tumor necrosis factor‑alpha
              J Neurosci Res 2011;89:13‑21.                       on astrocytes, microglia, oligodendrocytes, and glial precursors
           94.  Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K,   in vitro. Dev Neurosci 1991;13:130‑7.
              Kipp M, Baumgartner W, Stangel M. Astrocytes regulate myelin   108. Shigemoto‑Mogami Y, Hoshikawa K, Goldman JE, Sekino Y, Sato K.
              clearance through recruitment of microglia during cuprizone‑induced   Microglia enhance neurogenesis and oligodendrogenesis in the early
              demyelination. Brain 2013;136:147‑67.               postnatal subventricular zone. J Neurosci 2014;34:2231‑43.
           95.  Williams A, Piaton G, Lubetzki C. Astrocytes‑‑friends or foes in   109. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S,
              multiple sclerosis? Glia 2007;55:1300‑12.           Martino G, Schwartz M. Microglia activated by IL‑4 or IFN‑gamma
           96.  Patel JR, McCandless EE, Dorsey D, Klein RS. CXCR4 promotes   differentially induce neurogenesis and oligodendrogenesis from
              differentiation of oligodendrocyte progenitors and remyelination.   adult stem/progenitor cells. Mol Cell Neurosci 2006;31:149‑60.
              Proc Natl Acad Sci U S A 2010;107:11062‑7.      110. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor
           97.  Maysami  S, Nguyen  D, Zobel  F, Pitz  C, Heine  S, Hopfner  M,   alpha in brain injury. Cytokine Growth Factor Rev 1999;10:119‑30.
              Stangel M. Modulation of rat oligodendrocyte precursor cells by   111. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP.
              the chemokine CXCL12. Neuroreport 2006;17:1187‑90.  TNF alpha promotes proliferation of oligodendrocyte progenitors
           98.  Omari KM, John G, Lango R, Raine CS. Role for CXCR2 and   and remyelination. Nat Neurosci 2001;4:1116‑22.
              CXCL1 on glia in multiple sclerosis. Glia 2006;53:24‑31.  112. Kotter MR, Stadelmann C, Hartung HP. Enhancing remyelination
           99.  Hosking MP, Tirotta E, Ransohoff RM, Lane TE. CXCR2 signaling   in disease–can we wrap it up? Brain 2011;134:1882‑900.





































   272  Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015  Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015   273
   276   277   278   279   280   281   282   283   284   285   286